Synergistic effects of bortezomib with low dose melphalan against human AML cells.

被引：0
|
作者：
Gautier, M
Bubis, JA
Wu, JY
Meehan, KR
机构：
[1] Dartmouth Hitchcock Med Ctr, Hematol Oncol Sect, Lebanon, NH 03766 USA
[2] Dartmouth Hitchcock Med Ctr, Bone Marrow Transplantat Program, Lebanon, NH 03766 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.4463.4463
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4463
引用
收藏
页码：194B / 194B
页数：1
相关论文
共 50 条
  • [1] Synergistic inhibitory effects of low-dose decitabine in combination with bortezomib in the AML cell line Kasumi-1
    Mpakou, Vassiliki
    Spathis, Aris
    Bouhla, Anthi
    Mpazani, Efthimia
    Papageorgiou, Sotirios
    Gkontopoulos, Konstantinos
    Glezou, Eirini
    Thomopoulos, Thomas
    Foukas, Periklis
    Pappa, Vasiliki
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (03)
  • [2] Vorinostat is synergistic with melphalan and bortezomib on the in vitro and in vivo myeloma cells
    Macro, Margaret
    HEMATOLOGIE, 2010, 16 (02): : 112 - 112
  • [3] Effects of low dose neutrons applied at a very low dose rate on human melanoma cells.
    Dionet, C
    Tchirkov, A
    Alard, JP
    Arnold, J
    Dhermain, J
    Rapp, M
    Bodez, V
    Tamain, JC
    Monbel, I
    Malet, P
    Kwiatowski, F
    Donnarieix, D
    Veyre, A
    Verrelle, P
    EFFECTS OF LOW AND VERY LOW DOSES OF IONIZING RADIATION ON HUMAN HEALTH, PROCEEDINGS, 2000, 1203 : 255 - 259
  • [4] Synergistic cytotoxicity of Idarubicin and Melphalan in multiple myeloma cells.
    Tosi, P
    Pellacani, A
    Visani, G
    Benni, M
    Ronconi, S
    Cavo, M
    Tura, S
    BLOOD, 1997, 90 (10) : 4146 - 4146
  • [5] Low dose intravenous melphalan and bortezomib for relapsed multiple myeloma
    Popat, R
    Oakervee, HE
    Foot, N
    Agrawal, S
    Odeh, L
    Craddock, C
    Williams, C
    Basu, S
    Williams, C
    Basu, S
    Cavenagh, JD
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 98 - 98
  • [6] Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat, and bortezomib in lymphoma cells
    Teo, Esmeralda C.
    Valdez, Benigno C.
    Ji, Jie
    Li, Yang
    Liu, Yan
    Brammer, Jonathan E.
    Hosing, Chitra
    Nieto, Yago
    Champlin, Richard E.
    Andersson, Borje S.
    LEUKEMIA & LYMPHOMA, 2016, 57 (11) : 2644 - 2652
  • [7] The Effects of Low Dose Aspirin (LDA) on Human Endometrial Stromal Cells.
    de Paredes, Jessica Garcia
    Zhao, Qingshi
    Wu, Tracy
    Persaud, Manisha
    Morelli, Sara S.
    Douglas, Nataki C.
    REPRODUCTIVE SCIENCES, 2024, 31 : 254A - 254A
  • [8] Hematology: Synergistic effects of bortezomib and melphalan therapy in patients with multiple myeloma
    Higgs R.
    Nature Reviews Clinical Oncology, 2010, 7 (3) : 124 - 124
  • [9] CURCUMIN AND BORTEZOMIB HAVE SYNERGISTIC CYTOTOXIC EFFECTS AGAINST MULTIPLE MYELOMA CELLS
    Yosifov, D. Y.
    Guenova, M.
    Konstantinov, S. M.
    Berger, M. R.
    ANNALS OF ONCOLOGY, 2009, 20 : 33 - 33
  • [10] BORTEZOMIB, LOW DOSE INTRAVENOUS MELPHALAN AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED MULTIPLE MYELOMA
    Popat, R.
    Oakervee, H.
    Williams, C.
    Cook, M.
    Craddock, C.
    Basu, S.
    Singer, C.
    Odeh, L.
    Foot, N.
    Joel, S.
    Hallam, S.
    Harding, S.
    Mead, G.
    Cavenagh, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 365 - 366
12345